North America Insulin Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

North America Insulin Delivery Devices Market - Segmented by Type (Insulin Pens, Insulin Pumps, Insulin Syringes, and Jet Injectors) and by region

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The market for insulin delivery devices is directly dependent on the increasing diabetic population. North American region has witnessed an astounding increase in the prevalence of diabetes in patients in recent years. In developed countries, such as the United States and Canada, the rate of diabetes has been at an all-time high, mainly due to the environmental and lifestyle changes.

Scope of the Report

The North America Insulin Delivery Devices Market segmented into Insulin pens, Insulin pumps, Insulin Syringes, Jet Injectors. Insulin pens further segmented into Reusable pens (Cartridges) and Disposable pens, and Insulin Pump further segmented into the Insulin pump, Insulin pump reservoir & Infusion set.

By Product (Value and Volume, 2012-2024)
Reusable Insulin pens (Cartridges in Reusable pens)
Disposable Insulin Pens
Insulin Syringes
Insulin Jet Injectors
Insulin Infusion Pumps
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
North America (Value and Volume, 2012-2024)
Rest of North America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The technological innovaton is driving the insulin delivery market

  • The rising demand for insulin has led to tremendous R&D activities in manufacturing a different painless type of insulin deliverable devices, such as CGM integrated insulin pumps.
  • Initially, syringes were the only form of insulin delivery systems, which are considered to be painful and not user-friendly. Thus, companies like Novo Nordisk, Sanofi among others, have produced their own insulin pens. They have a specific set dosage, which is considered to be not only less painful to use but also reduces wastage of insulin. According to few studies, pens can limit the intake of insulin by administering accurate doses, when compared to patients using syringes.
North America Insulin Delivery Devices market

The Unites States hold the highest market share in North America insulin delivery device market

  • The United States (US) in the North American region has the highest diabetes population. Thus, the sales of insulin delivery devices are high in the US. The US accounts for close to 90% of the market share in the North American region.
  • The consumers in the region have high acceptance of new technology, which is expected to boost the sales of jet injectors market during the forecast period. 
USA Insulin delivery devices

Competitive Landscape

  • The Insulin Pens and Insulin Pumps market consolidated with few players held the significant market share in 2018. But the insulin syringe market is a highly fragmented market; many market players are local.
  • Mergers and acquisitions that happened between the players in the recent past helped the companies strengthen their market presence, for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Reusable Insulin pens (Cartridges in Reusable pens)

      2. 5.1.2 Disposable Insulin Pens

      3. 5.1.3 Insulin Syringes

      4. 5.1.4 Insulin Jet Injectors

      5. 5.1.5 Insulin Infusion Pumps

        1. Insulin Pump Device

        2. Insulin Pump Reservoir

        3. Infusion Set

    2. 5.2 Geography

      1. 5.2.1 North America (Value and Volume, 2012-2024)

        1. USA

        2. Canada

        3. Rest of North America


    1. 6.1 Becton and Dickenson

    2. 6.2 Medtronic

    3. 6.3 Insulet

    4. 6.4 Tandem

    5. 6.5 Ypsomed

    6. 6.6 Novo Nordisk

    7. 6.7 Sanofi

    8. 6.8 Eli Lilly


**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Insulin Delivery Devices Market market is studied from 2018 - 2026.

The North America Insulin Delivery Devices Market is growing at a CAGR of 0% over the next 5 years.

Novo Nordisk, Medtronic, Roche, Ypsomed, Becton and Dickenson are the major companies operating in North America Insulin Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!